Market hours 09/17, 15:59(ET)
23.72MMarket Cap
LossP/E TTM
Key Figures
0.440Open
--High
0.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
--Turnover Ratio
0.420Prev. Close
--Low
0.00Turnover
LossP/E Static
2.90P/B
0.00%Div Yield TTM
-310.39%ROA
4.00052wk High
--Volume Ratio
-19.45MNet Profit
56.35MShares
-0.5587EPS TTM
-0.86Beta
-495.61%ROE
0.39052wk Low
--Amplitude
--Gross Margin
23.72MMarket Cap
-1.71Reward/Risk
9.43%Risk Rate
Recent
Earnings
Transcripts

More news coming soon, stay tuned...
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
3.167Target Price
+645.10%Upside Space
Heartbeam Inc Latest Earnings Call Transcripts
HeartBeam (BEAT) Q2 2026 Earnings Call: FDA Filing, Lower Cash Burn and Commercial Launch
HeartBeam’s Q2 2026 earnings call covered a $5 million net loss, lower cash burn, FDA progress and early commercial rollout across four U.S. markets.
Financial Indicators
Currency: USD

Relevant data have not been disclosed by the company yet.
Currency: USD

Relevant data have not been disclosed by the company yet.
Earnings
Earnings / Forecast
-0.10/-0.09
Revenue / Forecast
--/80.00K
Heartbeam Inc Profile
HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
SectorHealthcare Equipment & Supplies
Ticker SymbolBEAT
Number of employees21
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|
| Strome Mezzanine Fund, L.P. | 5.87% |
|---|
| Schwartzberg (Andrew) | 3.54% |
|---|
| Vanguard Capital Management, LLC | 2.23% |
|---|
| Public Ventures LLC | 1.99% |
|---|
| Shareholder Types | Proportion |
|---|
| Individual Investor | 8.06% |
|---|
| Corporation | 7.86% |
|---|
| Investment Advisor | 7.40% |
|---|
| Investment Advisor/Hedge Fund | 1.15% |
|---|
FAQs
What is the current price of Heartbeam Inc (BEAT)?
The current price of Heartbeam Inc (BEAT) is 0.42.
What is the symbol of Heartbeam Inc?
The ticker symbol of Heartbeam Inc is BEAT.
What is the 52-week high of Heartbeam Inc?
The 52-week high of Heartbeam Inc is 4.00.
What is the 52-week low of Heartbeam Inc?
The 52-week low of Heartbeam Inc is 0.39.
What is the market capitalization of Heartbeam Inc?
The market capitalization of Heartbeam Inc is 23.72M.
Is Heartbeam Inc (BEAT) currently rated as Buy, Hold, or Sell?
According to analysts, Heartbeam Inc (BEAT) has an overall rating of Buy, with a price target of 3.17.
What is the Earnings Per Share (EPS TTM) of Heartbeam Inc (BEAT)?
The Earnings Per Share (EPS TTM) of Heartbeam Inc (BEAT) is -0.56.